566 related articles for article (PubMed ID: 23662828)
21. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
DiLuna ML; King JT; Knisely JP; Chiang VL
Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
[TBL] [Abstract][Full Text] [Related]
22. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
[TBL] [Abstract][Full Text] [Related]
23. Impact of preexisting tumor necrosis on the efficacy of stereotactic radiosurgery in the treatment of brain metastases in women with breast cancer.
Xu Z; Marko NF; Angelov L; Barnett GH; Chao ST; Vogelbaum MA; Suh JH; Weil RJ
Cancer; 2012 Mar; 118(5):1323-33. PubMed ID: 22009460
[TBL] [Abstract][Full Text] [Related]
24. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
[TBL] [Abstract][Full Text] [Related]
25. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
[TBL] [Abstract][Full Text] [Related]
26. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2003 Feb; 98(2):342-9. PubMed ID: 12593621
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic radiosurgery for multiple brain metastases from breast carcinoma.
Muacevic A; Kreth FW; Tonn JC; Wowra B
Cancer; 2004 Apr; 100(8):1705-11. PubMed ID: 15073860
[TBL] [Abstract][Full Text] [Related]
28. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
[TBL] [Abstract][Full Text] [Related]
29. Gamma Knife Radiosurgery for the Management of More Than 15 Cerebral Metastases.
Bowden G; Faramand A; Niranjan A; Lunsford LD; Monaco E
World Neurosurg; 2019 Jun; 126():e989-e997. PubMed ID: 30876993
[TBL] [Abstract][Full Text] [Related]
30. Gamma knife surgery for the treatment of intracranial metastases from breast cancer.
Goyal S; Prasad D; Harrell F; Matsumoto J; Rich T; Steiner L
J Neurosurg; 2005 Aug; 103(2):218-23. PubMed ID: 16175849
[TBL] [Abstract][Full Text] [Related]
31. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
[TBL] [Abstract][Full Text] [Related]
32. Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
Kano H; Iyer A; Kondziolka D; Niranjan A; Flickinger JC; Lunsford LD
Neurosurgery; 2011 Dec; 69(6):1232-9. PubMed ID: 21716155
[TBL] [Abstract][Full Text] [Related]
33. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article.
Salvetti DJ; Nagaraja TG; McNeill IT; Xu Z; Sheehan J
J Neurosurg; 2013 Jun; 118(6):1250-7. PubMed ID: 23540265
[TBL] [Abstract][Full Text] [Related]
34. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
35. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
37. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
[TBL] [Abstract][Full Text] [Related]
38. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?
Chang WS; Kim HY; Chang JW; Park YG; Chang JH
J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789
[TBL] [Abstract][Full Text] [Related]
39. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival.
Banfill KE; Bownes PJ; St Clair SE; Loughrey C; Hatfield P
Br J Neurosurg; 2012 Oct; 26(5):674-8. PubMed ID: 22747250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]